Saint Francis Health System

Allergy & Immunology Research Portfolio

Saint Francis Health System Allergy and Immunology Research clinical studies designed to improve the understanding and treatment of allergic and immune-mediated diseases. Our research focuses on evaluating the safety, effectiveness, and real-world use of innovative therapies that have the potential to improve quality of life for patients living with chronic allergic and immunologic conditions.

Saint Francis Health System Allergy and Immunology Research clinical studies designed to improve the understanding and treatment of allergic and immune-mediated diseases. Our research focuses on evaluating the safety, effectiveness, and real-world use of innovative therapies that have the potential to improve quality of life for patients living with chronic allergic and immunologic conditions.

REASSERT- NCT07358780 PI: Weyman Lam, MD

Prospective, non-interventional study in patients with CSU where the treatment decision prior enrolment has been made to either escalate current sgH1-AHs treatment or escalate/switch current treatment to remibrutinib. The primary aim of this study is to gather real-world effectiveness and safety data for remibrutinib, a new treatment option, covering a broader, real-world clinical practice population.

Study Details | NCT07358780 | Remibrutinib in Real-world Clinical Practice - a US Sub-study | ClinicalTrials.gov